Pubblicazioni

  • Home
  • Pubblicazioni
 
Disability assessment in the Google Maps era: a pilot study
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Disability improvement after alemtuzumab is associated with T2 lesion volume shrinkage in multiple sclerosis
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Effectiveness of Natalizumab on Multiple Sclerosis patients: the Italian registry experience
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Exposure to disease modifying drugs reduces disability progression in pediatric-, adult- and late-onset relapsing multiple sclerosis: real world data from the Early Multiple Sclerosis Italian Cohort (E-MUSIC)
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Is the antibody titer really useful to verify the immunization of VZV Vaccine in MS patient treated with Fingolimod?
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Patients reported outcome measures from relapsing remitting people with multiple sclerosis on first line disease modifying therapies in a real world settin
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
The Impact of Cognitive Testing on Disability Measurement during the Follow-up of People with Multiple Sclerosis
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
The Italian multiple sclerosis register
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Treatment choice after natalizumab discontinuation: results from an Italian multicenter retrospective study
Giacomo Lus
Giacomo Lus
Vai all’articolo »